| 789238 |
THERANOSTICS |
Turing milk into pro-apoptotic oral nanotherapeutic: De novo bionic chiral-peptide supramolecule for cancer targeted and immunological therapy |
2022-01-01 |
10.7150/thno.70568 |
He Wangxiao, Zhang Zhang, Yang Wenguang, Zheng Xiaoqiang, You Weiming, Yao Yu, Yan Jin, Liu Wenjia |
| 789237 |
THERANOSTICS |
SNX10-mediated degradation of LAMP2A by NSAIDs inhibits chaperone-mediated autophagy and induces hepatic lipid accumulation |
2022-01-01 |
10.7150/thno.70692 |
Lee Wonseok, Kim Hyun Young, Choi You-Jin, Jung Seung-Hwan, Nam Yoon Ah, Zhang Yunfan, Yun Sung Ho, Chang Tong-Shin, Lee Byung-Hoon |
| 789236 |
THERANOSTICS |
Hepatic RACK1 deficiency protects against fulminant hepatitis through myeloid-derived suppressor cells |
2022-01-01 |
10.7150/thno.65916 |
Liu Genyu, Wang Qingyang, Deng Lijiao, Huang Xiaofeng, Yang Guang, Cheng Qianqian, Guo Tingting, Guo Lu, Niu Chunxiao, Yang Xiqin, Dong Jie, Zhang Jiyan |
| 789235 |
THERANOSTICS |
Interleukin 33-mediated inhibition of A-type K+ channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice |
2022-01-01 |
10.7150/thno.69320 |
Wang Yiru, Wang Xinyi, Qi Renfei, Lu Ying, Tao Yu, Jiang Dongsheng, Sun Yufang, Jiang Xinghong, Liu Chunfeng, Zhang Yuan, Tao Jin |
| 789234 |
THERANOSTICS |
Ferroptotic stress promotes macrophages against intracellular bacteria |
2022-01-01 |
10.7150/thno.66663 |
Ma Ruonan, Fang Ling, Chen Lei, Wang Xiaonan, Jiang Jing, Gao Lizeng |
| 789233 |
THERANOSTICS |
Multi-modal molecular imaging maps the correlation between tumor microenvironments and nanomedicine distribution |
2022-01-01 |
10.7150/thno.68000 |
Strittmatter Nicole, Moss Jennifer I., Race Alan M., Sutton Daniel, Canales Jaime Rodriguez, Ling Stephanie, Wong Edmond, Wilson Joanne, Smith Aaron, Howes Colin, Bunch Josephine, Barry Simon T., Goodwin Richard J.A., Ashford Marianne B. |
| 789232 |
THERANOSTICS |
Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives |
2022-01-01 |
10.7150/thno.69628 |
Tang Lu, Li Jing, Pan Ting, Yin Yue, Mei Yijun, Xiao Qiaqia, Wang Ruotong, Yan Ziwei, Wang Wei |
| 789231 |
THERANOSTICS |
Platinum-based drugs for cancer therapy and anti-tumor strategies |
2022-01-01 |
10.7150/thno.69424 |
Zhang Chunyu, Xu Chao, Gao Xueyun, Yao Qingqiang |
| 789230 |
THERANOSTICS |
Rho Kinase regulates neutrophil NET formation that is involved in UVB-induced skin inflammation |
2022-01-01 |
10.7150/thno.66457 |
Li Minghui, Lyu Xing, Liao James, Werth Victoria P., Liu Ming-Lin |
| 789229 |
THERANOSTICS |
Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death |
2022-01-01 |
10.7150/thno.69119 |
Moon Yujeong, Shim Man Kyu, Choi Jiwoong, Yang Suah, Kim Jinseong, Yun Wan Su, Cho Hanhee, Park Jung Yeon, Kim Yongju, Seong Joon-Kyung, Kim Kwangmeyung |
